Aug 01, 2017 12:01 pm UTC| Business
BOSTON, Aug. 01, 2017 -- LogMeIn, Inc. (Nasdaq:LOGM) today announced that it has agreed to acquire Nanorep, an innovative digital self-service, chatbot and virtual assistant company. Headquartered in Herzliya, Israel,...
Interpace Diagnostics Launches Product Extension at World Conference on Thyroid Cancer
Aug 01, 2017 12:01 pm UTC| Business
BOSTON, Aug. 01, 2017 -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology...
Aug 01, 2017 12:01 pm UTC| Business
Targeting Approximately $100 Million in Cost-Savings to Increase Profitability and Drive Growth Committing to Significant Operating Margin Expansion Launching Search to Recruit Seasoned Independent Chairman of...
American Railcar Industries, Inc. Reports Second Quarter 2017 Results
Aug 01, 2017 12:01 pm UTC| Business
Second Quarter 2017 Highlights Quarterly revenue of $109.0 million Quarterly net earnings of $10.9 million, or $0.57 per shareQuarterly adjusted EBITDA of $37.0 million, or 34.0% of revenueLease fleet reaches 12,414...
Wealth Signs Letter Agreement to Acquire Interest in ‘Seven Salars’ Lithium Project in Chile
Aug 01, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, Aug. 01, 2017 -- Wealth Minerals Ltd. (the “Company” or “Wealth”) - (TSXV:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN) announces that it has executed a binding letter agreement (the...
iCAD to Present at the Canaccord Genuity 37th Annual Growth Conference
Aug 01, 2017 12:01 pm UTC| Business
NASHUA, N.H., Aug. 01, 2017 -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today...
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Aug 01, 2017 12:01 pm UTC| Business
BOSTON, Aug. 01, 2017 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...